Parkway Fund 3 LP · CIK 1967908
Parkway Fund 3 LP
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
0
Amendments
1
Activity
Mar 11, 2025
through Mar 11, 2025
through Mar 11, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- —
- Reported exemptions
- Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(1)
- Reported amount sold
- $9,826,471
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- OXOS MEDICAL, INC. · CIK 1694304
- Parkway Co-Investment 10 (xAI) QP LP · CIK 2023654
- Parkway Co-Investment 12 (Figure Series C) LP · CIK 2055676
- Parkway Co-Investment 12 (Figure Series C) QP LP · CIK 2055687
- Parkway Co-Investment 13 (SBQ SF) LP · CIK 2103638
Form D filings (1)
-
0001967908-25-000001D/A · Mar 11, 2025 · Pooled Investment FundSold: $9,826,471